Evidence map›Paper›PMID 25376243›Full record

ArticleBMC nephrology2014

The glomerular parietal epithelial cell's responses are influenced by SM22 alpha levels.

Shokichi Naito, Jeffrey W Pippin, Stuart J Shankland

Open access · goldAbstract read
In one paragraph

Article in BMC nephrology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Mice with aAmerican journal of physiology. Renal physiology · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Cells of NG2 lineage increase in glomeruli of mice following podocyte depletion.American journal of physiology. Renal physiology · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Changes in glomerular parietal epithelial cells in mouse kidneys with advanced age.American journal of physiology. Renal physiology · 2015
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Shokichi Naito
Jeffrey W Pippin
Stuart J ShanklandDivision of Nephrology Department of Medicine, University of Washington School of Medicine, Box 356521, 1959 NE Pacific St,, Seattle, WA 98195-6521, USA. stuartjs@u.washington.edu.
University of Washington · USKitasato University · JP

Funding

Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomerular diseaseR01DK097598 · NIDDK · UNIVERSITY OF WASHINGTON · PI SHANKLAND, STUART JAMES, WESSELY, OLIVER · 2014 to 2022
$5.2M
CELL CYCLE PROTEINS AND GLOMERULAR APOPTOSISR01DK056799 · NIDDK · UNIVERSITY OF WASHINGTON · PI SHANKLAND, STUART JAMES · 2000 to 2014
$3.6M
New Thoughts on Parietal Epithelial CellsR21DK081835 · NIDDK · UNIVERSITY OF WASHINGTON · PI SHANKLAND, STUART JAMES · 2009 to 2010
$429k
NIDDK NIH HHS R01 DK056799NIDDK NIH HHS R01DK056799NIDDK NIH HHS R01 DK097598NIDDK NIH HHS R21 DK081835NIDDK NIH HHS R21DK081835
6 · The paper itself

Abstract

backgroundStudies have shown in several diseases initially affecting podocytes, that the neighboring glomerular parietal epithelial cells (PECs) are secondarily involved. The PEC response might be reparative under certain circumstances, yet injurious under others. The factors governing these are not well understood. We have shown that SM22α, an actin-binding protein considered a marker of smooth muscle differentiation, is upregulated in podocytes and PECs in several models of podocyte disease. However, the impact of SM22α levels on PECs is not known.

methodsExperimental glomerular disease, characterized by primary podocyte injury, was induced in aged-matched SM22α+/+ and SM22α-/-mice by intraperitoneal injection of sheep anti-rabbit glomeruli antibody. Immunostaining methods were employed on days 7 and 14 of disease.

resultsThe number of PEC transition cells, defined as cells co-expressing a PEC protein (PAX2) and podocyte protein (Synaptopodin) was higher in diseased SM22α-/-mice compared with SM22α+/+mice. WT1 staining along Bowman's capsule is higher in diseased SM22α-/-mice. This was accompanied by increased PEC proliferation (measured by ki-67 staining), and an increase in immunostaining for the progenitor marker NCAM, in a subpopulation of PECs in diseased SM22α-/-mice. In addition, immunostaining for vimentin and alpha smooth muscle actin, markers of epithelial-to-mesenchymal transition (EMT), was lower in diseased SM22α-/-mice compared to diseased SM22α+/+mice.

conclusionSM22α levels may impact how PECs respond following a primary podocyte injury in experimental glomerular disease. Absent/lower levels favor an increase in PEC transition cells and PECs expressing a progenitor marker, and a lower EMT rate compared to SM22α+/+mice, where SM22 levels are markedly increased in PECs.

Indexed as

ActinsAnimalsBowman CapsuleCD56 AntigenCell DifferentiationCell DivisionEpithelial CellsEpithelial-Mesenchymal TransitionGlomerulonephritisKidney GlomerulusMaleMiceMice, TransgenicMicrofilament ProteinsMuscle ProteinsPAX2 Transcription FactorActinsCD56 AntigenMicrofilament ProteinsMuscle ProteinsNcam1 protein, mousePax2 protein, mousePAX2 Transcription FactorSynpo protein, mouseTagln protein, mouseTrypsin Inhibitor, Bowman-Birk SoybeanVimentin

Identifiers

PMID25376243
PMCPMC4247743
OpenAlexW2067102136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.